← Human Trials & Peer-Reviewed Studies

Combined laser acupuncture and desmopressin for treating resistant cases of monosymptomatic nocturnal enuresis: a randomized comparative study

Plain-language guide to PMID 24909996 (2014): randomized controlled trial study of Vasopressin and Desmopressin in 186 patients.

Key Facts

PMID
24909996
Journal
Scandinavian journal of urology
Year
2014
Study type
Randomized Controlled Trial
Authors
Moursy EE et al. (3 authors)
DOI
10.3109/21681805.2014.922609

What This Study Did, in Plain Language

What Was Tested

This randomized controlled trial paper looks at Vasopressin and Desmopressin.

Monosymptomatic nocturnal enuresis (MNE) is a common sociomedical problem affecting children that may persist until adulthood despite various lines of therapy.

Who Took Part

According to the abstract, 186 patients were involved.

The age groups tagged for this paper are children, teenagers and young adults, both men and women.

The study included 186 patients with a mean age of 15.7 years (range 10-21 years) presenting with persistent MNE.

All patients were evaluated clinically and investigated with urine analysis, plain X-ray of the urinary tract and abdominal ultrasonography.

How the Study Was Run

In design terms this was a randomized study.

Because people in this Vasopressin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

What Was Measured

The subject headings attached to it are Acupuncture Therapy, Antidiuretic Agents, Combined Modality Therapy, Deamino Arginine Vasopressin, Lasers, Semiconductor and Nocturnal Enuresis.

The authors tagged it with the keywords desmopressin, laser acupuncture and monosymptomatic nocturnal enuresis..

What This Means in Plain Language

The paper is a randomized study of Vasopressin and Desmopressin in 186 patients.

The abstract goes on to report its results in about 4 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2014 (Scandinavian journal of urology), a journal based in Sweden.

More context: the Vasopressin compound page and the Desmopressin compound page, all human trials.

Our Notes on the Compounds

Vasopressin: A 9-amino-acid hormone (antidiuretic hormone) that controls water balance and blood vessel tone; used in septic shock.

Desmopressin: A synthetic vasopressin analog (DDAVP) used for bedwetting, diabetes insipidus and some bleeding disorders.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.